Investor Relations

Events &
Presentations

Presentations

Presentations.

Date Title Files
Aug 8, 2026
Exposure/Response Analysis of an Oral Multi-Node PI3K/AKT/mTOR Pathway Inhibitor Combination of Serabelisib and Sapanisertib
Jun 15, 2026
Faeth Corporate Presentation June 2026

The drug product candidates described on this website are investigational agents that have not been approved by the Food and Drug Administration or any other regulatory authority. Their safety and efficacy have not been established.